S-ketamine Prevents Postoperative Pain and Cognitive Dysfunction After Tibial Fracture
S-ketamine Prevents Tibial Fracture-associated Postoperative Pain and Cognitive Dysfunction After Orthopedic Surgery in Patients: a Randomized Double-blind Controlled Trial
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 15, 2021
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Brief Summary
Purpose:
To explore effects of S-ketamine on postoperative pain and cognitive dysfunction after tibial fracture and orthopedic surgery.
To evaluate and examine the incidence of adverse effects with the purpose of selecting the optimum dose.
Registry Overview
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Recruitment status
unknown
Estimated enrollment
120 participants
Study completion date
December 15, 2021
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations
1 countries · 1 sites
Trial Relationships
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Related Scientific Literature
Loading related publications...
Study Timeline
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
First Submitted
November 17, 2020
Actual (reported)
First Posted
November 24, 2020
Actual (reported)
Study Start
December 15, 2020
Actual (reported)
Primary Completion
November 15, 2021
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 15, 2021
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Mechanical hyperalgesia threshold on the palms of feet
The mechanical hyperalgesia threshold was defined as the lowest force (g) necessary to bend a Von Frey filament, which was perceived to be painful by the patient and measured by Von Frey filament.
48 hours after surgery
Secondary Outcomes (7)
Pain Score (NRS)
48 hours after surgery
Mechanical Hyperalgesia Threshold on the Dominant Inner Forearm
48 hours after surgery
Time of First Postoperative Analgesic Requirement
1 hour after surgery
Total Dose of First Postoperative Analgesic Requirement
1 hour after surgery
Cumulative Sufentanyl Consumption
48 hours after surgery
+2 more secondary outcomes
Study Arms (3)
Normal saline in patients
PLACEBO COMPARATOR
After the induction of anesthesia, normal saline is intravenously injected in a volume of 2ml, and then a continuous infusion of 20 ml/h normal saline until starting skin suture.
Drug: Normal saline
S-ketamine at low dose in patients
ACTIVE COMPARATOR
After the induction of anesthesia, S-ketamine is intravenously injected at 0.2mg/kg, and then a continuous infusion of 0.2mg/kg/h S-ketamine until starting skin suture.
Drug: S-ketamine (low-dose)
S-ketamine at high dose in patients
ACTIVE COMPARATOR
Interventions
Normal salineDrug
After the induction of anesthesia, normal saline is intravenously injected in a volume of 2ml, and then a continuous infusion of 20ml/h normal saline until starting skin suture.
Also known as: 0. 9% Sodium Chloride Injection
Normal saline in patients
S-ketamine (low-dose)Drug
After the induction of anesthesia, S-ketamine is intravenously injected at 0.2mg/kg, and then a continuous infusion of 0.2mg/kg/h S-ketamine until starting skin suture.
Registry intervention entries
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Administration procedure
S-ketamine (low-dose)
The registry describes an administration procedure or treatment schedule. Actual exposure and doses are not established by this entry.
Zhang L, Terrando N, Xu ZZ, Bang S, Jordt SE, Maixner W, Serhan CN, Ji RR. Distinct Analgesic Actions of DHA and DHA-Derived Specialized Pro-Resolving Mediators on Post-operative Pain After Bone Fracture in Mice. Front Pharmacol. 2018 May 1;9:412. doi: 10.3389/fphar.2018.00412. eCollection 2018.
Cui W, Li Y, Wang Z, Song C, Yu Y, Wang G, Li J, Wang C, Zhang L. Spinal caspase-6 regulates AMPA receptor trafficking and dendritic spine plasticity through netrin-1 in postoperative pain after orthopedic surgery for tibial fracture in mice. Pain. 2021 Jan;162(1):124-134. doi: 10.1097/j.pain.0000000000002021.
After the induction of anesthesia, S-ketamine is intravenously injected at 0.4mg/kg, and then a continuous infusion of 0.4mg/kg/h S-ketamine until starting skin suture.
Drug: S-ketamine (high-dose)
Also known as: Esketamine Hydrochloride Injection
S-ketamine at low dose in patients
S-ketamine (high-dose)Drug
After the induction of anesthesia, S-ketamine is intravenously injected at 0.4mg/kg, and then a continuous infusion of 0.4mg/kg/h S-ketamine until starting skin suture.
Also known as: Esketamine Hydrochloride Injection
S-ketamine at high dose in patients
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
The subject's parent/legally authorized guardian has given written informed consent to participate.
You may not qualify if:
Subject has a diagnosis of bronchial asthma, coronary heart disease, severe hypertension, renal failure or liver failure.
Subject has a diagnosis of Insulin dependent diabetes.
Subject is allergy and contraindication to S-ketamine.
Subject has a history of chronic pain, a history of alcohol or opioid abuse, pre- existing therapy with opioids.
Subject has any contraindication for the use of patient-controlled analgesia (PCA).
Subject is pregnant or breast-feeding.
Subject is obese (body mass index \>30kg/m\^2).
Subject is incapacity to comprehend pain assessment and cognitive assessment.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 15, 2021
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
August 13, 2021
Record last verified: 2021-08
Data Sharing
IPD Sharing
Will not share
Source record
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.